n-acetyllactosamine has been researched along with Lymphoma, B-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bensa, JC; Chaperot, L; Galili, U; Lui, G; Manches, O; Molens, JP; Plumas, J; Sotto, JJ | 1 |
1 other study(ies) available for n-acetyllactosamine and Lymphoma, B-Cell
Article | Year |
---|---|
Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Topics: Amino Sugars; Animals; Antigen Presentation; Antigen-Presenting Cells; Antigens, Neoplasm; Callithrix; Cancer Vaccines; Cells, Cultured; Galactosyltransferases; Glycosylation; Humans; Immunity, Innate; Immunization; Immunoglobulin G; Immunotherapy; Lymphocyte Activation; Lymphoma, B-Cell; Neoplastic Stem Cells; Neuraminidase; Phagocytosis; Receptors, IgG; Recombinant Fusion Proteins; T-Lymphocyte Subsets; Trisaccharides | 2005 |